HCA continues to witness growth in reported and same-facility admissions. The company reaffirms 2025 guidance.
The headline numbers for HCA (HCA) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
HCA Healthcare (HCA) came out with quarterly earnings of $6.45 per share, beating the Zacks Consensus Estimate of $5.77 per share. This compares to earnings of $5.36 per share a year ago.
HCA Healthcare (HCA 1.64%), a prominent player in the healthcare sector, announced robust first-quarter results for 2025 on Friday, April 25, that surpassed market expectations. The company recorded an adjusted EPS of $6.45 for Q1 2025, exceeding the anticipated $5.75.
Hospital operator HCA Healthcare said on Friday its first-quarter profit rose nearly 9%, as more people underwent elective procedures and sought medical care due to a rise in flu cases.
HCA's first-quarter earnings are likely to have benefited from growing admissions.
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for HCA (HCA), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2025.
I believe HCA Healthcare is currently undervalued, especially after a recent 20.9% share price drop, making it a compelling 'buy' candidate. HCA Healthcare's financial performance has been solid, with revenue rising 5.7% year-over-year, driven by increased hospital traffic and higher revenue per admission. Despite mixed profitability metrics, management's forecast for 2025 shows expected revenue growth and higher profits, reinforcing my bullish stance.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is a recession coming? Our economic outlook seems increasingly gloomy due to President Trump's trade policies.
HCA Healthcare shares have gained 5% over the past year, with potential Medicaid cuts posing a modest future risk to revenue. Despite potential Medicaid cuts, HCA's relatively low Medicaid exposure (11% of revenue) limits the impact to about 0.5% of revenue. HCA's strong financial performance, including $5.6 billion in free cash flow and robust buybacks, supports ongoing capital returns to investors.
Here is how HCA Healthcare (HCA) and Brookdale Senior Living (BKD) have performed compared to their sector so far this year.